{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Inflammation", "Lung fibrosis", "Metabonomics", "Nigella sativa oil", "TGF\u03b2", "Urine"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "28412654", "DateCompleted": {"Year": "2018", "Month": "02", "Day": "23"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "08"}, "Article": {"ArticleDate": [{"Year": "2017", "Month": "04", "Day": "14"}], "Language": ["eng"], "ELocationID": ["10.1016/j.biopha.2017.04.009", "S0753-3322(17)30580-2"], "Journal": {"ISSN": "1950-6007", "JournalIssue": {"Volume": "90", "PubDate": {"Year": "2017", "Month": "Jun"}}, "Title": "Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie", "ISOAbbreviation": "Biomed Pharmacother"}, "ArticleTitle": "Nigella sativa, a traditional Tunisian herbal medicine, attenuates bleomycin-induced pulmonary fibrosis in a rat model.", "Pagination": {"StartPage": "626", "EndPage": "637", "MedlinePgn": "626-637"}, "Abstract": {"AbstractText": ["The present study investigated the effects of Nigella sativa oil (NSO) on bleomycin (BLM)-induced lung fibrosis in rats. The rat model of pulmonary fibrosis (PF) was established by intratracheal instillation of BLM, and the effect of 1ml/kg oral NSO treatment once daily observed. The effect of NSO was studied over a period of 50daysusing <sup>1</sup>H RMN analysis on the urine and broncho alveolar lavage fluid (Balf) of the rats. Histopathological (inflammation and fibrosis) and immunohistochemical (TGF-\u03b21 density) changes were evaluated. Results found that the BLM group showed a significant increase in inflammatory index (II), fibrosis score (FS) and TGF-\u03b21 distribution in the lung inflammatory infiltrate, accompanied by a decreased urinary secretion of Krebs cycle intermediates, including acetate, pyruvate, carnitine, trimethylamine-N-oxide and succinate. However, at the same time point, NSO treated rats had a reduced II and FS, and had an increased urinary secretion of histidine, fumarate, allantoin and malate. In conclusion, NSO treatment attenuated the effects of BLM-induced PF, by supporting lung, liver and kidney activity in resisting PF. These findings provide an insight into the preventive and therapeutic potential of NSO in the treatment of PF."], "CopyrightInformation": "Copyright \u00a9 2017 Elsevier Masson SAS. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Physiology, Faculty of Medicine of Tunis, University of Tunis El Manar, La Rabta, Tunis 1007, Tunisia. Electronic address: abidi_anouar3@yahoo.fr."}], "LastName": "Abidi", "ForeName": "Anouar", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Physiology and Pharmacology, Faculty of Medicine of Mons, University of Mons, Mons 7000, Belgium."}], "LastName": "Robbe", "ForeName": "Alexandre", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Anatomy and Pathology, Charles Nicolle Hospital, Tunis 1007, Tunisia."}], "LastName": "Kourda", "ForeName": "Nadia", "Initials": "N"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Physiology, Faculty of Medicine of Tunis, University of Tunis El Manar, La Rabta, Tunis 1007, Tunisia."}], "LastName": "Ben Khamsa", "ForeName": "Saloua", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Physiology and Pharmacology, Faculty of Medicine of Mons, University of Mons, Mons 7000, Belgium."}], "LastName": "Legrand", "ForeName": "Alexandre", "Initials": "A"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "France", "MedlineTA": "Biomed Pharmacother", "NlmUniqueID": "8213295", "ISSNLinking": "0753-3322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Transforming Growth Factor beta1"}, {"RegistryNumber": "11056-06-7", "NameOfSubstance": "Bleomycin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Bleomycin"}, {"QualifierName": ["chemistry"], "DescriptorName": "Bronchoalveolar Lavage Fluid"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": ["methods"], "DescriptorName": "Herbal Medicine"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Inflammation"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Lung"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["methods"], "DescriptorName": "Medicine, Traditional"}, {"QualifierName": ["chemistry"], "DescriptorName": "Nigella sativa"}, {"QualifierName": ["methods"], "DescriptorName": "Phytotherapy"}, {"QualifierName": ["blood", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemically induced", "drug therapy", "metabolism"], "DescriptorName": "Pulmonary Fibrosis"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": [], "DescriptorName": "Rats, Wistar"}, {"QualifierName": ["metabolism"], "DescriptorName": "Transforming Growth Factor beta1"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2017", "Month": "2", "Day": "7"}, {"Year": "2017", "Month": "3", "Day": "21"}, {"Year": "2017", "Month": "4", "Day": "6"}, {"Year": "2017", "Month": "4", "Day": "17", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "2", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "4", "Day": "17", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["28412654", "10.1016/j.biopha.2017.04.009", "S0753-3322(17)30580-2"]}}]}